Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Cystic Fibrosis | 13 | 2019 | 1104 | 1.88 | Why? |
| Cystic Fibrosis Transmembrane Conductance Regulator | 6 | 2019 | 113 | 1.86 | Why? |
| Cause of Death | 4 | 2021 | 4823 | 1.02 | Why? |
| Indians, South American | 1 | 2020 | 126 | 0.78 | Why? |
| Chlorides | 5 | 2019 | 82 | 0.73 | Why? |
| Exocrine Pancreatic Insufficiency | 1 | 2018 | 14 | 0.73 | Why? |
| Solute Carrier Proteins | 1 | 2017 | 3 | 0.72 | Why? |
| Public Sector | 1 | 2020 | 204 | 0.72 | Why? |
| Private Sector | 1 | 2020 | 262 | 0.70 | Why? |
| Sweat | 5 | 2019 | 127 | 0.69 | Why? |
| Polymorphism, Single Nucleotide | 5 | 2018 | 3607 | 0.69 | Why? |
| Publications | 1 | 2021 | 463 | 0.61 | Why? |
| Federal Government | 1 | 2020 | 562 | 0.53 | Why? |
| Brazil | 14 | 2021 | 12582 | 0.52 | Why? |
| Bronchodilator Agents | 1 | 2017 | 444 | 0.46 | Why? |
| Interleukin-8 | 1 | 2017 | 964 | 0.44 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.37 | Why? |
| Periodicals as Topic | 1 | 2021 | 1492 | 0.35 | Why? |
| Politics | 1 | 2021 | 1824 | 0.34 | Why? |
| Sodium | 3 | 2018 | 309 | 0.33 | Why? |
| Spirometry | 3 | 2019 | 524 | 0.31 | Why? |
| Health Services Accessibility | 2 | 2020 | 10697 | 0.31 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 2984 | 0.30 | Why? |
| Ultrasonography | 1 | 2021 | 4409 | 0.28 | Why? |
| Genotype | 7 | 2019 | 4697 | 0.24 | Why? |
| Healthcare Disparities | 1 | 2020 | 3893 | 0.23 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.23 | Why? |
| Social Medicine | 1 | 2021 | 27 | 0.23 | Why? |
| Polymorphism, Restriction Fragment Length | 2 | 2017 | 116 | 0.21 | Why? |
| Salivary Proteins and Peptides | 1 | 2019 | 12 | 0.21 | Why? |
| Pierre Robin Syndrome | 1 | 2018 | 2 | 0.19 | Why? |
| Tropical Climate | 1 | 2020 | 179 | 0.19 | Why? |
| Renal Tubular Transport, Inborn Errors | 1 | 2018 | 6 | 0.19 | Why? |
| Growth | 1 | 2018 | 19 | 0.19 | Why? |
| Financial Support | 1 | 2020 | 170 | 0.18 | Why? |
| Hypercalciuria | 1 | 2018 | 8 | 0.18 | Why? |
| Hypophosphatemia | 1 | 2018 | 11 | 0.18 | Why? |
| Parenteral Nutrition, Total | 1 | 2018 | 17 | 0.18 | Why? |
| Nephrocalcinosis | 1 | 2018 | 14 | 0.18 | Why? |
| Burkholderia | 1 | 2017 | 5 | 0.18 | Why? |
| Adiponectin | 1 | 2019 | 123 | 0.18 | Why? |
| Capnography | 1 | 2018 | 32 | 0.18 | Why? |
| Nitric Oxide Synthase Type II | 1 | 2017 | 119 | 0.18 | Why? |
| Orgasm | 1 | 2017 | 20 | 0.18 | Why? |
| Burkholderia Infections | 1 | 2017 | 33 | 0.17 | Why? |
| Femur | 1 | 2018 | 100 | 0.17 | Why? |
| Body Height | 1 | 2018 | 100 | 0.17 | Why? |
| Estrogen Receptor beta | 1 | 2017 | 14 | 0.17 | Why? |
| Bronchiolitis, Viral | 1 | 2017 | 71 | 0.17 | Why? |
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2017 | 37 | 0.17 | Why? |
| Muscular Dystrophy, Duchenne | 1 | 2019 | 129 | 0.17 | Why? |
| Receptors, Calcitriol | 1 | 2017 | 102 | 0.17 | Why? |
| Chemokine CCL5 | 1 | 2017 | 169 | 0.17 | Why? |
| Estrogen Receptor alpha | 1 | 2017 | 40 | 0.17 | Why? |
| Hypertriglyceridemia | 1 | 2018 | 90 | 0.16 | Why? |
| Motor Activity | 1 | 2019 | 217 | 0.16 | Why? |
| Saline Solution, Hypertonic | 1 | 2017 | 81 | 0.16 | Why? |
| Bed Occupancy | 1 | 2020 | 476 | 0.16 | Why? |
| Survival Analysis | 2 | 2020 | 7592 | 0.16 | Why? |
| Genetic Testing | 1 | 2019 | 395 | 0.15 | Why? |
| Gene Frequency | 2 | 2018 | 1210 | 0.15 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.15 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.15 | Why? |
| Hypokalemia | 1 | 2018 | 195 | 0.15 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.14 | Why? |
| Lung | 3 | 2021 | 31049 | 0.14 | Why? |
| Toll-Like Receptors | 1 | 2017 | 365 | 0.14 | Why? |
| Infant | 9 | 2020 | 30274 | 0.14 | Why? |
| Walk Test | 1 | 2017 | 461 | 0.14 | Why? |
| Child Development | 1 | 2018 | 352 | 0.13 | Why? |
| Haplotypes | 1 | 2017 | 853 | 0.13 | Why? |
| Government Regulation | 1 | 2021 | 842 | 0.13 | Why? |
| Bronchiolitis | 1 | 2017 | 297 | 0.13 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.13 | Why? |
| Child, Preschool | 9 | 2020 | 36283 | 0.13 | Why? |
| Respiration | 1 | 2019 | 729 | 0.13 | Why? |
| Child | 12 | 2020 | 70012 | 0.12 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.12 | Why? |
| Humans | 32 | 2021 | 930598 | 0.12 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2018 | 952 | 0.12 | Why? |
| Genetic Predisposition to Disease | 4 | 2020 | 4027 | 0.12 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.11 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.11 | Why? |
| Adolescent | 12 | 2020 | 86841 | 0.11 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.11 | Why? |
| Lipids | 1 | 2018 | 1079 | 0.11 | Why? |
| Prevalence | 4 | 2020 | 25773 | 0.11 | Why? |
| Needs Assessment | 1 | 2021 | 2352 | 0.11 | Why? |
| Infant, Newborn | 7 | 2020 | 23105 | 0.11 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2017 | 846 | 0.10 | Why? |
| Male | 20 | 2020 | 367725 | 0.10 | Why? |
| Female | 21 | 2020 | 380317 | 0.10 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.10 | Why? |
| Organizational Innovation | 1 | 2020 | 2468 | 0.10 | Why? |
| DNA, Viral | 1 | 2020 | 2521 | 0.10 | Why? |
| Young Adult | 10 | 2020 | 93724 | 0.10 | Why? |
| Polymorphism, Genetic | 1 | 2017 | 1074 | 0.10 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.10 | Why? |
| Reproducibility of Results | 3 | 2020 | 11304 | 0.09 | Why? |
| Sputum | 1 | 2017 | 1720 | 0.09 | Why? |
| Breast Neoplasms | 2 | 2017 | 3633 | 0.09 | Why? |
| Polymerase Chain Reaction | 3 | 2017 | 6740 | 0.09 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2017 | 1234 | 0.09 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.08 | Why? |
| Disease Progression | 3 | 2021 | 13580 | 0.08 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.08 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.07 | Why? |
| Social Support | 1 | 2020 | 3183 | 0.07 | Why? |
| Middle Aged | 11 | 2020 | 270681 | 0.07 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.07 | Why? |
| Anti-HIV Agents | 1 | 2018 | 2209 | 0.07 | Why? |
| Diagnostic Tests, Routine | 1 | 2017 | 2643 | 0.07 | Why? |
| Severity of Illness Index | 5 | 2020 | 48226 | 0.07 | Why? |
| Cross-Sectional Studies | 8 | 2019 | 53120 | 0.07 | Why? |
| Adult | 12 | 2020 | 244371 | 0.07 | Why? |
| Aged | 9 | 2020 | 215776 | 0.06 | Why? |
| Aged, 80 and over | 5 | 2020 | 88759 | 0.06 | Why? |
| Saliva | 1 | 2018 | 4679 | 0.06 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.05 | Why? |
| Genes, Modifier | 1 | 2019 | 7 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Introns | 1 | 2019 | 112 | 0.05 | Why? |
| Facies | 1 | 2018 | 15 | 0.05 | Why? |
| Exons | 1 | 2019 | 158 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.05 | Why? |
| Motor Disorders | 1 | 2019 | 45 | 0.05 | Why? |
| Inflammation | 2 | 2018 | 13255 | 0.04 | Why? |
| Twins, Monozygotic | 1 | 2018 | 83 | 0.04 | Why? |
| Protein-Energy Malnutrition | 1 | 2018 | 37 | 0.04 | Why? |
| Toll-Like Receptor 9 | 1 | 2017 | 72 | 0.04 | Why? |
| Exercise | 1 | 2018 | 6771 | 0.04 | Why? |
| Respiratory Muscles | 1 | 2019 | 116 | 0.04 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2018 | 6653 | 0.04 | Why? |
| Phenotype | 2 | 2019 | 4037 | 0.04 | Why? |
| Lipoproteins, LDL | 1 | 2018 | 115 | 0.04 | Why? |
| Private Facilities | 1 | 2017 | 50 | 0.04 | Why? |
| Minerals | 1 | 2018 | 86 | 0.04 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.04 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.04 | Why? |
| Toll-Like Receptor 2 | 1 | 2017 | 198 | 0.04 | Why? |
| Vital Capacity | 1 | 2018 | 399 | 0.04 | Why? |
| Lipoproteins, HDL | 1 | 2018 | 154 | 0.04 | Why? |
| Bacterial Typing Techniques | 1 | 2017 | 273 | 0.04 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.04 | Why? |
| Muscle Strength | 1 | 2019 | 317 | 0.04 | Why? |
| Electric Impedance | 1 | 2018 | 283 | 0.04 | Why? |
| Genetic Markers | 1 | 2017 | 318 | 0.04 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2017 | 6817 | 0.04 | Why? |
| Public Facilities | 1 | 2017 | 153 | 0.04 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.04 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.04 | Why? |
| Gene Deletion | 1 | 2017 | 430 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Triglycerides | 1 | 2018 | 478 | 0.04 | Why? |
| Forced Expiratory Volume | 1 | 2018 | 632 | 0.04 | Why? |
| Magnesium | 1 | 2018 | 290 | 0.04 | Why? |
| Genetic Counseling | 1 | 2017 | 229 | 0.04 | Why? |
| Prenatal Diagnosis | 1 | 2017 | 345 | 0.04 | Why? |
| Bacteriological Techniques | 1 | 2017 | 239 | 0.03 | Why? |
| Exhalation | 1 | 2018 | 441 | 0.03 | Why? |
| Toll-Like Receptor 4 | 1 | 2017 | 390 | 0.03 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.03 | Why? |
| Walking | 1 | 2019 | 442 | 0.03 | Why? |
| Case-Control Studies | 3 | 2018 | 17671 | 0.03 | Why? |
| Cholesterol | 1 | 2018 | 660 | 0.03 | Why? |
| Respiration Disorders | 1 | 2019 | 526 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2018 | 1444 | 0.03 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
| Exercise Test | 1 | 2018 | 911 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Carbon Dioxide | 1 | 2018 | 917 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2018 | 1755 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2017 | 1647 | 0.03 | Why? |
| Biomarkers | 3 | 2018 | 23361 | 0.03 | Why? |
| Radiography | 1 | 2018 | 1576 | 0.03 | Why? |
| Heart Rate | 1 | 2019 | 1527 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
| Nasopharynx | 2 | 2017 | 10224 | 0.02 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.02 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.02 | Why? |
| Nutritional Status | 1 | 2018 | 1403 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Pregnancy | 2 | 2018 | 23879 | 0.02 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.02 | Why? |
| Symptom Assessment | 1 | 2018 | 4967 | 0.02 | Why? |
| Cohort Studies | 2 | 2017 | 36005 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.01 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.01 | Why? |
| Specimen Handling | 1 | 2018 | 6190 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Hospitalization | 2 | 2018 | 54280 | 0.01 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
| Age Factors | 1 | 2016 | 21039 | 0.01 | Why? |
| Critical Illness | 1 | 2018 | 17281 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Retrospective Studies | 1 | 2017 | 105322 | 0.00 | Why? |